With cannabis legalization and decriminalization on the rise around the globe, Organigram Holdings Inc. (NASDAQ: OGI; TSX: OGI) has now joined a number of advocacy boards to further those efforts. 

Cameron Bishop, the company’s VP of Public Affairs and Stakeholder Relations, is now officially advising four separate international cannabis advocacy organizations, covering European, Canadian, and American territories.  

As of Monday morning, Bishop currently serves on the boards for these groups: 

  • European Alliance for Medical Cannabis 
  • The American Trade Association for Cannabis and Hemp 
  • The Policy Center for Public Health & Safety 
  • Cannabis Council of Canada (appointed vice chair)

Discussing the newly appointed board member, Policy Center for Public Health & Safety Chair Fred Niehaus commented: 

Organigram brings an invaluable global perspective and we are honored to have the company as part of our team. In the regulatory environment surrounding the cannabis industry, it is essential to have representatives who are both knowledgeable and credible. Mr. Bishop’s thoughtful interaction with stakeholders will serve the industry well.

Recreational cannabis has seen legalization in 11 U.S. states as of October, with three times that number allowing medical usage with a variety of stipulations and regulatory frameworks. 

There has been continued movement towards additional legalization in the U.S. in the past month, as the SAFE Bank Act recently passed the House of Representatives. 

If that bill is subsequently passed by the Senate and signed into law by the Trump administration, it will allow cannabis businesses to work with banks despite marijuana remaining a banned Schedule I drug at the federal level. 

While nationwide legalization is expected to be a Presidential campaign issue, a number of states are already looking to put recreational legalization directly on the ballot via voter initiative. 

Two separate groups currently working towards that goal in Florida, while lawmakers in other states are expected to take up various legalization bills next year. Canadian licensed producers are eagerly awaiting new legalization attempts as they seek to utilize their existing infrastructure in the U.S. market.

In other Organigram news, the company recently received Health Canada approval for 17 additional grow rooms. The company’s stock is currently trading at $3.32 this morning, down from nearly $5 a share this time last month and a high of $8.35 back in May